Yahoo
NasdaqGS - Delayed Quote USD

Revolution Medicines, Inc. (RVMD)

210.02 -0.85 (-0.40%)
At close: September 4 at 4:00:00 PM EDT
210.46 +0.44 (+0.21%)
After hours: September 4 at 7:56:15 PM EDT
Trade RVMD on Coinbase

Financials

Updated 13h ago
Powered by Yahoo Scout

Revolution Medicines Inc's financial metrics present a concerning picture, with EBITDA growth declining by 94.84%in Q2 2026, indicating severe operational challenges. EPS growth fell by 96.45%, reflecting deteriorating profitability for shareholders. Valuation metrics remain at 0.00x, suggesting a lack of market confidence in future earnings potential.

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
44.99B 40.12B 19.47B 15.69B 8.86B 6.88B
Enterprise Value
41.69B 38.37B 17.60B 13.92B 6.86B 4.91B
Trailing P/E
-- -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (5yr expected)
-- -- -- -- -- --
Price/Sales
9.04k -- -- -- -- --
Price/Book
17.26 26.75 11.93 9.83 4.75 3.31
Enterprise Value/Revenue
8.37k -- -- -- -- --
Enterprise Value/EBITDA
-- -- -- -- -- --
6/30/2025 - 2/13/2020

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -30.12%
Return on Equity (ttm) -79.09%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) -1.3B
EBITDA -1.62B
Net Income Avi to Common (ttm) -1.77B
Diluted EPS (ttm) -8.84
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 3.94B
Total Cash Per Share (mrq) 18.37
Total Debt (mrq) 1.19B
Total Debt/Equity (mrq) 45.68%
Current Ratio (mrq) 11.38
Book Value Per Share (mrq) 7.49

Cash Flow Statement

Operating Cash Flow (ttm) -1.22B
Levered Free Cash Flow (ttm) -711.61M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52 Week Change 3 411.50%
S&P 500 52-Week Change 3 19.28%
52 Week High 3 224.31
52 Week Low 3 39.73
50-Day Moving Average 3 196.79
200-Day Moving Average 3 134.06

Share Statistics

Avg Vol (3 month) 3 2.31M
Avg Vol (10 day) 3 1.93M
Shares Outstanding 5 214.34M
Implied Shares Outstanding 6 214.34M
Float 8 184.52M
% Held by Insiders 1 1.88%
% Held by Institutions 1 101.07%
Shares Short (8/14/2026) 4 9.72M
Short Ratio (8/14/2026) 4 5.49
Short % of Float (8/14/2026) 4 4.79%
Short % of Shares Outstanding (8/14/2026) 4 4.53%
Shares Short (prior month 7/15/2026) 4 14M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: